| |
| |
|
| Insider
Information: |
Poyhonen John |
| Relationship: |
President & CCO |
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
46,648 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$161,869 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
46,648 |
|
|
| Total
Value |
$161,869 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Senomyx Inc |
SNMX |
President & CEO, Direc... |
2018-11-02 |
0 |
2018-11-02 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2011-06-03 |
0 |
2009-05-19 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
President & CCO |
2023-04-13 |
46,648 |
2017-01-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2023-04-13 |
4 |
D |
$2.88 |
$5,795 |
D/D |
(2,012) |
46,648 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2023-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
48,660 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2023-01-13 |
4 |
D |
$3.17 |
$6,378 |
D/D |
(2,012) |
42,846 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2023-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
44,858 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-10-13 |
4 |
D |
$3.76 |
$7,565 |
D/D |
(2,012) |
39,044 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
41,056 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-07-13 |
4 |
D |
$3.01 |
$6,056 |
D/D |
(2,012) |
35,242 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
37,254 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
29,650 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2022-01-13 |
4 |
D |
$8.30 |
$16,700 |
D/D |
(2,012) |
27,638 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-10-29 |
4 |
A |
$9.36 |
$7,646 |
D/D |
817 |
23,836 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-10-13 |
4 |
D |
$10.55 |
$4,568 |
D/D |
(433) |
23,019 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
23,452 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
22,635 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-07-13 |
4 |
D |
$13.48 |
$5,837 |
D/D |
(433) |
22,202 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-04-30 |
4 |
A |
$13.90 |
$13,494 |
D/D |
971 |
21,385 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-04-13 |
4 |
D |
$16.66 |
$7,214 |
D/D |
(433) |
20,414 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
20,847 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
20,030 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2021-01-13 |
4 |
D |
$18.16 |
$7,863 |
D/D |
(433) |
19,597 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
President & CCO |
• – – |
2020-10-30 |
4 |
A |
$11.65 |
$7,423 |
D/D |
637 |
18,780 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Chief Commercial Officer |
• • – |
2019-10-03 |
4 |
B |
$17.50 |
$90,003 |
D/D |
5,143 |
18,143 |
2.81 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2019-05-22 |
4 |
B |
$17.55 |
$52,650 |
D/D |
3,000 |
13,000 |
2.39 |
- |
|
| SNMX |
Senomyx Inc |
President & CEO |
• • – |
2018-11-02 |
4 |
D |
$1.50 |
$162,440 |
I/I |
(108,293) |
0 |
0 |
- |
|
| SNMX |
Senomyx Inc |
President & CEO |
• • – |
2018-11-02 |
4 |
D |
$1.50 |
$167,204 |
D/D |
(111,469) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
